John Hiscott, Ph.D. - Full Member
John Hiscott, Ph.D., a world-renowned molecular biologist and
virologist, is a principal investigator and full member of VGTI Florida.
Dr. Hiscott’s work has focused on the innate immune response to
infectious diseases, cancer and AIDS. His work has provided major
contributions to the understanding of the immune system’s response to
viruses such as hepatitis C, influenza and HIV. His work has appeared in
more than 80 peer-review articles published in prestigious scientific
journals around the world, such as the European Journal of Immunology,
Cellular Microbiology and Cancer Research.
Dr. Hiscott also served as the director of the Molecular Oncology Group at the Lady Davis Research Institute of the Jewish General Hospital, which is affiliated with McGill University in Montreal. He also served as a professor in the departments of medicine, microbiology and immunology, and oncology at the university.
For his work, Dr. Hiscott has earned numerous awards and distinctions, including the Milstein Award, which is given by the International Society of Interferon and Cytokine Research for the pinnacle of scientific achievement in fighting such diseases as cancer, hepatitis, influenza and autoimmune disorders. He was the recipient of the Scientist and Senior Scientist awards from the Canadian Institutes of Health Research. He has also received the Distinguished Service Award from the Israel Cancer Research Fund, an Award for Excellence in Medical Research from Jewish General Hospital, and is a member of Canadian’s Who’s Who. He is a member of several scientific journal editorial boards, and in 2006 was appointed editor-in-chief of Cytokine and Growth Factors Review, a leading immunology journal.
Dr. Hiscott earned his doctorate in medical sciences from New York University Medical Center, and he completed his post-doctoral training at the Roche Institute in New Jersey, and the Institute for Molecular Biology at the University of Zurich in Switzerland.
Dr. Hiscott also served as the director of the Molecular Oncology Group at the Lady Davis Research Institute of the Jewish General Hospital, which is affiliated with McGill University in Montreal. He also served as a professor in the departments of medicine, microbiology and immunology, and oncology at the university.
For his work, Dr. Hiscott has earned numerous awards and distinctions, including the Milstein Award, which is given by the International Society of Interferon and Cytokine Research for the pinnacle of scientific achievement in fighting such diseases as cancer, hepatitis, influenza and autoimmune disorders. He was the recipient of the Scientist and Senior Scientist awards from the Canadian Institutes of Health Research. He has also received the Distinguished Service Award from the Israel Cancer Research Fund, an Award for Excellence in Medical Research from Jewish General Hospital, and is a member of Canadian’s Who’s Who. He is a member of several scientific journal editorial boards, and in 2006 was appointed editor-in-chief of Cytokine and Growth Factors Review, a leading immunology journal.
Dr. Hiscott earned his doctorate in medical sciences from New York University Medical Center, and he completed his post-doctoral training at the Roche Institute in New Jersey, and the Institute for Molecular Biology at the University of Zurich in Switzerland.
